KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Depreciation & Amortization (CF): 2010-2025

Historic Depreciation & Amortization (CF) for Opko Health (OPK) over the last 15 years, with Sep 2025 value amounting to $22.7 million.

  • Opko Health's Depreciation & Amortization (CF) fell 5.89% to $22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.3 million, marking a year-over-year decrease of 6.82%. This contributed to the annual value of $98.2 million for FY2024, which is 6.76% down from last year.
  • Opko Health's Depreciation & Amortization (CF) amounted to $22.7 million in Q3 2025, which was down 1.25% from $23.0 million recorded in Q2 2025.
  • Opko Health's Depreciation & Amortization (CF)'s 5-year high stood at $28.0 million during Q2 2022, with a 5-year trough of $19.0 million in Q3 2021.
  • For the 3-year period, Opko Health's Depreciation & Amortization (CF) averaged around $24.8 million, with its median value being $24.2 million (2024).
  • As far as peak fluctuations go, Opko Health's Depreciation & Amortization (CF) dropped by 9.85% in 2021, and later surged by 47.63% in 2022.
  • Quarterly analysis of 5 years shows Opko Health's Depreciation & Amortization (CF) stood at $19.2 million in 2021, then soared by 37.88% to $26.5 million in 2022, then fell by 1.81% to $26.0 million in 2023, then declined by 7.48% to $24.0 million in 2024, then fell by 5.89% to $22.7 million in 2025.
  • Its last three reported values are $22.7 million in Q3 2025, $23.0 million for Q2 2025, and $23.5 million during Q1 2025.